$6.42 0.32 (+5.25%)
2/9/2010 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating: 5 out of 5

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

Current Price $6.42 Mkt Cap $689.42M
Open $6.19 P/E Ratio 0.00
Prev. Close $6.10 Div. (Yield) N/A (N/A)
Daily Range $6.12 - $6.43 Volume 743,335
52-Wk Range $4.09 - $8.00 Avg. Daily Vol. 0

EXEL News and Commentary

View All EXEL News and Commentary

Caps

How do you think EXEL will perform vs the S&P 500?

Add Stock to Watchlist

All Members

2,276 Outperform
83 Underperform
 

All-Star Members

650 Outperform
22 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top EXEL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

jbonds (90.40)
Submitted May 28, 2009

Exelixis and Sanofi-Aventis sign global license agreement for XL147 & XL765 and launch collaboration for discovery of PI3K inhibitors Sanofi-Aventis (SNY) and co announce a global license agreement for XL147 and XL765 and a collaboration for the… More

0 Comments | Reply | Report this Post

BRADYstocks (76.71)
Submitted February 26, 2008

This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.

0 Comments | Reply | Report this Post
EXEL VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about EXEL.

Recs

0
Member Avatar Biotech2010 (40.47) Submitted: 1/26/2010 8:50:26 PM : Outperform Start Price: $6.66 EXEL Score: -1.82

@7.48

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar doandrew (46.49) Submitted: 1/26/2010 4:36:17 PM : Underperform Start Price: $6.66 EXEL Score: +1.82

Company still has a negative balance sheet, cash flow and loosing money.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar slowneasy1031 (32.14) Submitted: 1/26/2010 6:14:23 AM : Outperform Start Price: $6.39 EXEL Score: +2.38

This stock has the backing of all the major pharms. They have plenty of cash for the next 2 years and I believe they are a prime candidate for a takeover

Report this Post 0 Comments | Reply | Permalink
View All 377 Pitches »

Leaderboard

Find the members with the highest scoring picks in EXEL.

Score Leader

Nordaak

Nordaak (96.48) Score: +129.77

The Score Leader is the member with the highest score across all their picks in EXEL.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
Nordaak 96.48 11/21/2008 Outperform NS $2.34 +174.36% +44.59% +129.77
Renegadecj 81.33 11/24/2008 Outperform 5Y $2.50 +156.80% +32.01% +124.79
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. BringUs 68.96 11/26/2008 Outperform NS $2.56 +150.78% +30.41% +120.37
TRock1081 95.27 11/24/2008 Outperform 5Y $2.57 +149.81% +31.38% +118.43
botso < 20 11/21/2008 Outperform 5Y $2.48 +158.87% +44.60% +114.27
massexile < 20 11/24/2008 Outperform 1Y $2.71 +136.90% +33.94% +102.96
MattH42004 99.90 10/29/2008 Outperform 5Y $3.02 +112.58% +17.86% +94.72 1 Comment
trsteff < 20 11/25/2008 Outperform 5Y $2.91 +120.62% +25.91% +94.71
nvmk < 20 11/25/2008 Outperform 1Y $2.91 +120.62% +25.91% +94.71
SlotRacer 79.93 10/30/2008 Outperform 1Y $3.11 +106.43% +14.51% +91.92 2 Comments
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackIcahn 32.10 2/24/2009 Outperform 1Y $4.69 +36.89% +44.93% -8.05 1 Comment
TrackMerriman < 20 10/16/2008 Outperform NS $4.15 +71.08% +21.49% +49.60 11/18/2009 @ $7.10
TrackCanaccord 86.15 7/8/2008 Outperform NS $5.19 +12.91% +1.82% +11.08 8/6/2008 @ $5.86
TrackSoros 82.58 3/31/2008 Outperform NS $6.95 -7.63% -15.75% +8.12 1 Comment
TrackEveillard 93.31 12/31/2007 Outperform NS $8.63 -25.61% -23.57% -2.04 1 Comment
TrackLazardCapit < 20 9/14/2007 Outperform NS $10.44 -38.51% -23.94% -14.57

Featured Broker Partners